Formulations of oxabicycloheptanes and oxabicycloheptenes
US10532050B2 · kind B2 · utility
5Cited by
18References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 8, 2014 |
| Grant date | Jan 14, 2020 |
| Priority date | — |
| Expiry date | Jul 5, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a pharmaceutical composition comprising a protein phosphatase 2A (PP2A) inhibitor and monosodium glutamate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.